Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...
The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...
Medicare will seek to negotiate lower prices for Novo Nordisk's popular but pricey GLP-1 drugs Ozempic, Wegovy and Rybelsus, ...
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...